
Full length SARS-CoV-2 spike protein with glycans running in MD shows vastly altered accessibility for small molecules and antibodies (aka #glycotime for the #COVID19 #demogorgon) @LCasalino88 (movie) @zied_gaieb @abbydommer @AmaroLab

Transplant surgeon at University of Cincinnati since 1999.

Full length SARS-CoV-2 spike protein with glycans running in MD shows vastly altered accessibility for small molecules and antibodies (aka #glycotime for the #COVID19 #demogorgon) @LCasalino88 (movie) @zied_gaieb @abbydommer @AmaroLab

2023 Texas A&M QB commit Eli Holstein rocking the ‘We Ain’t Done Yet’ t shirt today.

Steve Spurrier on Texas jump to SEC: ‘They can’t win the Big 12 anyway.’ https://t.co/DoYG71MS8u

Longhorn fans during their first run through the SEC gauntlet

An important paper by prominent scientists proposing widely available and alternative approaches for immunotherapy to prevent SARS CoV 2 infection. The Sabin oral polio vaccine may have advantages over BCG.

Can existing live vaccines prevent COVID-19? science.sciencemag.org/conte…

Great article from Nature on the history of how the coronavirus jumped from bats to humans and why it is such a powerful infectious agent

Profile of a killer: the complex biology powering the coronavirus pandemic nature.com/articles/d41586-0…

Steve Scalise just said he would support a bill to revoke the $25 million funding from the Kennedy Center. They laid off a majority of their staff and musicians without pay in the middle of a crisis, AFTER we gave them taxpayer dollars. RT if the money should be taken back!

New national transplant data is out. Kidney transplant rates at U of Cincinnati show 71.1 transplants/100 patient-years on the waiting list. That means 71.1% of patients on our waiting list were transplanted last year. One of the highest transplant rates in the US🔥🔥🔥!!!

full text of our recent research Reducing Donor Specific Antibody During Acute Rejection... : Transplantation journals.lww.com/transplantj…

The American Journal of Transplantation podcast for February highlights 4 papers, 3 of which are from U of Cincinnati! The discussants comment was "Cincinnati rocks this month" the podcast link is below- skip to 15:34 podbean.com/eu/pb-x722w-d230…

We also show for the first time that the very worst form of antibody mediated rejection- which occurs beyond six months posttransplant can also respond to treatment.

Another important scientific publication from UC Transplant today was highlighted in the journal Transplantation. For the first time we show that within 2 weeks we can tell the impact of rejection treatment for the most dangerous type of rejection- antibody mediated rejection!

The most exciting thing about carfilzomib is that we are just beginning to tap its potential, and we are working toward improving the results even more with ongoing research!!

We were just notified by the American Journal of Transplantation that two of our papers published in February were selected for podcast and tweets! The research shows the promise of carfilzomib for eliminating antibodies- the major reason why kidney and heart transplants fail.